Daily Stock Opinions and Ratings

Latest Stock Buy or Sell? Make More Informed Decisions!

Today, David Driscoll and Pete Najarian commented about whether LCID-Q, MQ-Q, OXY-N, GS-N, ABBV-N, MRNA-Q, ARKK-ARCA, DOV-Q, AMZN-Q, TMO-N, BAM-N are stocks to buy or sell.

Page 1/2

COMMENT

Believes downward pressure on markets will continue as interest rates continue to rise. Raising capital for small cap and technology companies will become more expensive. Opportunity in bonds as yields rise. More bullish on bonds than stocks.

COMMENT

Believes further room for S&P 500 to drop as historical P/E average (16x) lower than today (20x). Not buying any stocks and is waiting for markets to fall further. Expecting further drops in the summer.

BUY ON WEAKNESS

Waiting to see which direction company takes with upcoming spinoff planned. Rising interest rates will present pressures on private equity (more expensive to raise capital). Buy a small amount of shares now, and wait until spinoff plans are announced in the fall.

BUY

Has owned company for 5 years. Is a good company to own within sector (way ahead of competition). Stock has fallen recently which is presenting good buying opportunity (25x P/E ratio). Dividend growing nicely with strong M&A activity. Buy shares now and if the price falls, buy more.

SELL

Company seeing diminished growth in business units (retail, AWS etc.) Law of diminishing returns is catching up with company (can't grow forever). 63x P/E ratio doesn't provide much room for healthy growth. Would sell shares and wait to buy when market reaches bottom.

BUY

Manufacturing sector not able to keep up with inflation which is causing problems for the company. Current share price presenting good opportunity to buy. Financial metrics are as good or better than competitors within the industry. Quality company that executes well with industry.

COMMENT

energy outlook He holds 30% energy including green and oil, and continues to add to it. Crude oil prices will pause here and there which is normal, but will continue to climb.

COMMENT

options He trimmed his ARKK and ARKF yesterday when they hit 52-week lows. Today, they're rising. ARKF was a great trade, though he's holding onto the ARKK because he has more time; the put-buying had nailed the short-term pulling back.

BUY

Biotechs have strong balance sheets, better than a few years ago. Likes this as well as Amgen. Better to buy individual biotech stocks over ETFs.

COMMENT

Biotechs have strong balance sheets, better than a few years ago. Likes this as well as Amgen. Better to buy individual biotech stocks over ETFs. He has options calls on Abbvie.

BUY

He bought around $312. Likes their 1x price-to-book ratio vs. JPM's 1.5x They did well on their earnings

COMMENT

options It was trading just beneath $63. A big buyer added 5,000 of the June 67.50 calls were bought for for $3.25 and selling an upside call against it.

COMMENT

options It dropped from $37 to $8.50 today. It sees a buyer of 10,000 of the June 10 calls at 65 cents. Interesting trade--was looking for a bounce for this stock.

COMMENT

options Trading just under $18. Today there was a buyer of 23,000 of the May 20 calls at 27-50 cents, fairly cheap with a little (not a lot) of time to play out. The EV space has taken a bad hit, but bouncing today.

DON'T BUY

She sold URI. Held it for a long time and it did well for her. As supply chains ease, the rental market will decline as people buy more.

Most Recent Experts

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Rebecca Teltscher

Newhaven Asset Management

Rick Rule

Rule Investment Media

Stockchase Insights

5i Research

Jim Cramer - Mad Money

CNBC

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Latest Stock Buy or Sell? Make More Informed Decisions!

A Comment -- General Comments From an Expert(A Commentary)

A Comment -- General Comments From an Expert(A Commentary)

Brookfield Asset Management Inc.(BAM-N)

Thermo Fisher Scientific(TMO-N)

Amazon.com, Inc.(AMZN-Q)

Dover Corporation(DOV-Q)

energy outlook(A Commentary)

ARK Innovation ETF(ARKK-ARCA)

Moderna(MRNA-Q)

AbbVie Inc.(ABBV-N)

Goldman Sachs(GS-N)

Occidental Petroleum Corp(OXY-N)

Marqeta(MQ-Q)

Lucid Group(LCID-Q)

United Rentals(URI-N)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals

Most Recent Experts

The Panic-Proof Portfolio (Stockchase Research)

Rebecca Teltscher

Rick Rule

Stockchase Insights

Jim Cramer - Mad Money